Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Corneal crosslinking treatment of progressive keratoconus using the photosensitiser riboflavin and ultraviolet A light (UVA) was introduced by Wollensak et al1 in Germany in 2003 and has become increasingly popular in recent years.2 3 Long-term results have confirmed the earlier positive results.3
The success of the new crosslinking method in the treatment of progressive keratoconus is based primarily on its biomechanical stiffening effect, stabilising the corneal collagen fibril …
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.